About us
Created in 2010 with the support of the “Grenoble Alpes Incubation” (“GRAIN”) business incubator, Ecrins Therapeutics is a spin-off from the Grenoble Institute of Neurosciences and Joseph Fourier University.
A prize winner of the 2009 and 2010 National Innovation Contest MENRT/ANVAR “Emergence” and “Création-Développement” Grants, the team of Ecrins Therapeutics pursues the pre-clinical and clinical development of new candidate anti-cancer medicines. The company was founded by Drs. Aurélie Juhem and Andrei Popov, supported by Prof. François Berger of the University Joseph Fourier, and the Grenoble University Hospital. Prior to the creation of start-up, the project was awarded the grant “Proof of concept” by the Lyon Auvergne Rhône-Alpes Cancéropôle (CLARA).
Customized Solutions for Your Business
We conduct cutting-edge research in biochemistry and provide customized solutions to our clients based on their specific needs.
Projects
Mich Stark, CTO
Founder and visionary, John is the driving force behind BioChemLab. He is committed to making a positive impact on the world through the power of biochemistry.
John Fred, COO
As a former research scientist with a PhD in biochemistry, Mich has the expertise and knowledge to lead BioChemLab to success. His passion for innovation and dedication to quality make him an invaluable asset to the team.
Dr. Sarah Lee, Chief Scientist
Dr. Sarah Lee is a highly respected researcher in the field of biochemistry. Her leadership and mentorship have been instrumental in the development of our team and products.
Iris Joe, CFO
Iris brings a wealth of financial expertise to BioChemLab. Her strategic insights and financial acumen have been instrumental in our success, and we are grateful to have her on our team.